Isorhamnetin inhibits cholangiocarcinoma proliferation and metastasis via PI3K/AKT signaling pathway | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Isorhamnetin inhibits cholangiocarcinoma proliferation and metastasis via PI3K/AKT signaling pathway

Authors:: Zhiguo Tan; Jie Liu; Min Hou; Jia Zhou; Yu Chen; Xu Chen; Yufang Leng

Reference:: Discover Oncology; 2025; 16; 469

DOI:: 10.1007/s12672-025-02217-8

See Abstract

Key Words:: Cholangiocarcinoma; HCCC9810; RBE; isorhamnetin; epithelial mesenchymal transition; PI3K/AKT; network pharmacology; molecular docking

Back to index